Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806024 · ClinicalTrials.gov registry record · Phase 4
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
A Phase 4 study of Cesarean Section and Postpartum Hemorrhage, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02806024 is a Phase 4 study of Cesarean Section and Postpartum Hemorrhage that has completed, run by University of California, San Francisco. The registered enrollment target is 14 participants, below the 169-participant average among 14 other Cesarean Section trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02806024, a Phase 4 study of Cesarean Section and Postpartum Hemorrhage, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine if intravenous tranexamic acid (TXA) is effective for reducing blood loss during high risk surgical procedures related to placenta previa and placenta accreta. TXA is currently used in other types of surgery for patients who are expected to have a large blood loss, such as orthopedic or open heart surgery.
Conditions Studied
Interventions
- DRUG Tranexamic Acid
- DRUG Placebo Drug
Study Locations (1)
California
- Community Regional Medical Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02806024
The ClinicalTrials.gov registry entry for NCT02806024 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 169-participant average among 14 other Cesarean Section trials with a reported enrollment target (92% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT02806024 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02806024 about?
NCT02806024 is a clinical study titled "Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study". The purpose of this pilot study is to determine if intravenous tranexamic acid (TXA) is effective for reducing blood loss during high risk surgical procedures related to placenta previa and placenta accreta. TXA is currently used in other types of surgery for patients who are expected to have a larg...
What is the current status of trial NCT02806024?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2016-11. Estimated completion is 2018-08.
What conditions does trial NCT02806024 study?
This clinical trial studies the following conditions: Cesarean Section, Postpartum Hemorrhage, Tranexamic Acid, Placenta Accreta.
What interventions are being tested in trial NCT02806024?
The interventions under investigation include: Tranexamic Acid (DRUG), Placebo Drug (DRUG).
Who is sponsoring clinical trial NCT02806024?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02806024 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Section
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intrathecal Dexmedetomidine vs Epinephrine
RECRUITING · Phase 4
-
Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose
COMPLETED · Phase 4
-
Seprafilm® Adhesion Barrier and Cesarean Delivery
COMPLETED · Phase 4
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
RECRUITING · NA
-
Post-operative Cesarean Trial of Pain Control
RECRUITING · NA
-
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.